Press releases
- MindMed to be Included in Russell 2000® and Russell 3000® Indexes
- MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
- MindMed Announces Constructive End-of-Phase 2 Meeting with U.S. FDA for MM120 in Generalized Anxiety Disorder (GAD)
- MindMed to Participate in June Conferences
- MindMed to Participate at May Investor Conferences
- New Studies Presented at the International Society for Health Economics and Outcomes Research Meeting (ISPOR 24) Show Growing Burden and Impact of Generalized Anxiety Disorder (GAD) in the US
- MindMed Reports First Quarter 2024 Financial Results and Business Updates
- MindMed Presents Phase 2b Study of MM120 for Generalized Anxiety Disorder (GAD) at American Psychiatric Association (APA) Annual Meeting in New York
- MindMed to Host Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Business Update
- MindMed to Present at Upcoming May Medical Conferences
More ▼
Key statistics
As of last trade, Mind Medicine (MindMed) Inc (MMQ:DEU) traded at 6.58, 196.71% above the 52 week low of 2.22 set on Nov 17, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.53 |
---|---|
High | 6.66 |
Low | 6.42 |
Bid | 6.45 |
Offer | 6.53 |
Previous close | 6.54 |
Average volume | 2.68k |
---|---|
Shares outstanding | 71.87m |
Free float | 69.95m |
P/E (TTM) | -- |
Market cap | 500.23m USD |
EPS (TTM) | -2.94 USD |
Data delayed at least 15 minutes, as of Jul 02 2024.
More ▼